Free shipping on all orders over $ 500

Acteoside

Cat. No. M4450
Acteoside Structure
Synonym:

Verbascoside; Kusaginin; TJC160

Size Price Availability Quantity
10mg USD 90  USD90 In stock
20mg USD 135  USD135 In stock
50mg USD 288  USD288 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Acteoside is isolated from Acanthus mollis, acts as an ATP-competitive inhibitor of PKC, with an IC50 of 25 µM, and has antitumor, anti-inflammatory and antineuropathic pain activity. Acteoside has potent antitumor activity against L-1210 cells, with an IC50 of 13 µM. Acteoside (5, 10 µM) suppresses 2,4-dinitrochlorobenzene (DNCB)-induced T cell costimulatory factors CD86 and CD54, proinflammatory cytokines, and NFκB pathway activation in THP-1 cells.

Chemical Information
Molecular Weight 624.59
Formula C29H36O15
CAS Number 61276-17-3
Solubility (25°C) DMSO ≥ 60 mg/mL
Water ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Yan Liu, et al. Acteoside, the Main Bioactive Compound in Osmanthus fragrans Flowers, Palliates Experimental Colitis in Mice by Regulating the Gut Microbiota

[2] Yuanyuan Wu, et al. Inhibitory activity of acteoside in melanoma via regulation of the ERβ-Ras/Raf1-STAT3 pathway

[3] HyangI Lim, et al. Acteoside Counteracts Interleukin-1 β-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NF κ B Cellular Signaling Pathway

[4] Di Ma, et al. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study

[5] Yanqing Zhou, et al. Current advances in acteoside biosynthesis pathway elucidation and biosynthesis

Related PKC Products
PKC β pseudosubstrate

PKC β pseudosubstrate is a selective cell-permeable inhibitor of PKC.

Protein Kinase C (19-31)

Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), is used as protein kinase C substrate peptide for testing the protein kinase C activity.

Protein Kinase C (19-36)

Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.

[Ala113]MBP(104-118)

[Ala113]MBP(104-118) is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 28-62 μM.

[Ala107]MBP(104-118)

[Ala107]MBP(104-118) is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Acteoside, Verbascoside; Kusaginin; TJC160 supplier, PKC, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.